Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
JACC. Cardiooncology
|
August 24, 2023
Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: <i>JACC: CardioOncology</i> State-of-the-Art Review
Darryl P Leong, Filipe Cirne, Nazanin Aghel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2015
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gregory A Masters, Sarah Temin, Christopher G Azzoli, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 6, 2019
A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapy
Katharine Mackett, Sukhbinder Dhesy-Thind, Elysia K Donovan, et al.
JACC. Cardiooncology
|
August 16, 2021
Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity: A Phase I Trial
Darryl P Leong, Tammy Cosman, Muhammad M Alhussein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2007
Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer
Charles A Butts, David Bodkin, Edward L Middleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2017
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update
Mark G Kris, Laurie E Gaspar, Jamie E Chaft, et al.
JACC. Cardiooncology
|
January 13, 2025
Cardiovascular Considerations During Cancer Therapy: Gaps in Evidence and <i>JACC: CardioOncology</i> Expert Panel Recommendations
Darryl P Leong, Sarah Waliany, Husam Abdel-Qadir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2017
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Nasser Hanna, David Johnson, Sarah Temin, et al.
Journal of Oncology Practice
|
October 6, 2017
Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients
Thomas J Smith, Nasser Hanna, David Johnson, et al.
Radiation Oncology (London, England)
|
November 8, 2024
Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy
Fiorella Di Pastena, Gregory Pond, Evangelia E Tsakiridis, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
JACC. Cardiooncology
|
August 24, 2023
Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: <i>JACC: CardioOncology</i> State-of-the-Art Review
Darryl P Leong, Filipe Cirne, Nazanin Aghel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2015
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gregory A Masters, Sarah Temin, Christopher G Azzoli, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 6, 2019
A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapy
Katharine Mackett, Sukhbinder Dhesy-Thind, Elysia K Donovan, et al.
JACC. Cardiooncology
|
August 16, 2021
Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity: A Phase I Trial
Darryl P Leong, Tammy Cosman, Muhammad M Alhussein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2007
Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer
Charles A Butts, David Bodkin, Edward L Middleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2017
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update
Mark G Kris, Laurie E Gaspar, Jamie E Chaft, et al.
JACC. Cardiooncology
|
January 13, 2025
Cardiovascular Considerations During Cancer Therapy: Gaps in Evidence and <i>JACC: CardioOncology</i> Expert Panel Recommendations
Darryl P Leong, Sarah Waliany, Husam Abdel-Qadir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2017
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Nasser Hanna, David Johnson, Sarah Temin, et al.
Journal of Oncology Practice
|
October 6, 2017
Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients
Thomas J Smith, Nasser Hanna, David Johnson, et al.
Radiation Oncology (London, England)
|
November 8, 2024
Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy
Fiorella Di Pastena, Gregory Pond, Evangelia E Tsakiridis, et al.
Page
of 10